Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Hematology
Disease Category: Acute Myelogenous Leukemia (AML)
Trial Information
Acute Myelogenous Leukemia (AML) - Adults
People with acute myelogenous leukemia (AML) are asked to participate in a research study being conducted by Monter Cancer Center.
You may be eligible to participate in this study if you:
- Are male or female at least 18-60 years of age at the time of relapse
- Have been diagnosed with AML
- Are male or female must agree to practice effective birth control during the study period and for 3 months afterward if not otherwise documented to be infertile
You may not participate in this study if you:
- Subjects with locally advanced solid tumors, 5 years from initial diagnosis
- Have any serious medical condition, laboratory abnormality or psychiatric illness that would prevent obtaining informed consent
- Clinical evidence of active leukemia (invasion of the brain or spinal cord).
- Have an active and uncontrolled infection
- Current evidence of invasive fungal infection (blood or tissue culture); HIV or active hepatitis C infection
- Allergy to cytarabine, daunorubicin or liposomal products
- History of Wilson’s disease or other copper-related disorder
Marjorie Fricano, Study Coordinator
Biomedical Research Alliance of New York
Monter Cancer Center
450 Lakeville Road
Lake Success, NY 11042
Phone: 516-734-8942
Fax: 516-734-8909
EMail: mfricano@nshs.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
